Close Menu

Columbia

NEW YORK (GenomeWeb News) – A year after it launched its effort to fund research that uses the latest technologies to tackle particularly interesting or difficult problems in cancer research and treatment, the National Cancer Institute has recently awarded millions to fund new projects and has r

NEW YORK (GenomeWeb News) – The National Human Genome Research Institute said today that it has pumped $19 million into new research and development projects that seek to bring down the costs of DNA sequencing.

Columbia University of New York has received US Patent No.

This is the second in a series of profiles of projects awarded NHGRI grants to develop policy guidelines on how and when to disclose secondary information to the subjects of genomic research studies.

A team from Columbia University is carrying out a set of interviews and surveys they intend to use to create guidelines for acquiring informed consent from subjects of genomic sequencing studies for the return of "incidental," or secondary, findings.

Columbia University of New York has received US Patent No.

Fluidigm of South San Francisco, Calif., has received US Patent No.

This story was originally posted on March 29.
By Justin Petrone

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Columbia University's trustees today sued Illumina claiming infringement of five patents covering methods for next-generation sequencing.

Columbia University of New York has received US Patent No. 8,133,492, "Pneumococcus polysaccharide-related vaccines." Nitrocellulose-based or hydrogel-based microarrays and methods of making them are claimed.

Pages

The Washington Post reports that the CDC's SARS-CoV-2 test issues reflect earlier ones it had with Zika virus testing.

NPR writes that even with thousands of new COVID-19 papers, each should be evaluated based on its own quality.

Researchers traced a gene cluster linked to COVID-19 severity to Neanderthals, the New York Times reports.

In PNAS this week: soil bacteria-derived small molecules affect centrosomal protein, microfluidics approach for capturing circulating tumor cells, and more.